Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event ending the wait, and that this is the main current work. Let's analyze the transcript. Management discusses five growth vectors: private brands reimagination, off-mall stores, marketplace, luxury, and personalized offers. They are investing in these. For example, private brands: they have built capabilities, hired teams, conducted research, and are launching new brands in back half of 2023. They mention INC update in mid-2022 with favorable results. But is there a specific cost currently being borne with no benefit yet? They talk about investments in SG&A, CapEx, etc. But they also say they are targeting sales growth beginning in 2024. They are making strategic investments reflected in 2023 SG&A and CapEx. However, the question asks if management describes the company as CURRENTLY LIVING THROUGH A DEFINED WAITING PERIOD — that is, paying now for something not yet earning, with a specific near-dated event ending the wait. Let's look for specific language. They mention "we are currently targeting low single-digit annual net sales and comparable owned plus license sales growth beginning in 2024" and "we are making strategic investments to fuel future profitable growth and these investments are reflected in our 2023 SG&A and CapEx assumptions." They also say "we will be testing, investing and scaling for sales and margin expansion." But is there a specific event? For private brands, they say "The new brands start to launch in the back half of '23" and "we have a very aggressive schedule going through all – through 2025." For off-mall, they plan to open 4 Market by Macy's and 1 Bloomie's in 2023, and if they outperform, accelerate in 2024. For marketplace, they plan to add 2,000 brands this year and launch Bloomingdale's marketplace in back half. For luxury, they are renovating stores. For personalization, they are running tests and expect meaningful benefit by end of 2024. But the question is about a defined waiting period where the company is paying now for something not yet earning, and the end is a specific near-dated event. Management does not explicitly say "we are currently bearing costs with no benefit yet" in a way that matches the description.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.